<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ920108-0123</DOCNO><DOCID>920108-0123.</DOCID><HL>   Who's News:   Neozyme Corp.</HL><DATE>01/08/92</DATE><SO>WALL STREET JOURNAL (J), PAGE B4</SO><CO>   GENZ NEOZ WNEWS</CO><MS>TECHNOLOGY (TEC)</MS><IN>BIOTECHNOLOGY (BTC)MEDICAL andamp; BIOTECHNOLOGY, GENETIC RESEARCH, PROSTHETICS (MTC)</IN><NS>PERSONNEL ANNOUNCEMENTS, PROMOTIONS, APPOINTMENTS (PER)</NS><RE>MASSACHUSETTS (MA)NORTH AMERICA (NME)UNITED STATES (US)</RE><LP>   NEOZYME Corp. (Cambridge, Mass.) -- This biotechnologycompany said it named Greg D. Phelps president. He succeedsElliott D. Hillback Jr. Mr. Phelps, 40 years old, alsosucceeds Mr. Hillback, 46, as senior vice president,corporate development at Genzyme Corp. Neozyme was formed byGenzyme in October 1990 to fund research and development of aselect group of Genzyme products. Mr. Hillback, who ispresident and chief executive officer of IG LaboratoriesInc., a majority owned subsidiary of Genzyme, resigned theposts at Neozyme and Genzyme to devote more time to IGLaboratories, a genetics testing services company. He remainsa director of Neozyme and an officer of Genzyme. The sharesof Genzyme, IG Labs and Neozyme all trade separately. Mr.Phelps was previously president and chief executive officerof Viagene Inc., a San Diego company involved in developinggene therapies for viral disease and cancers.</LP><TEXT/></DOC>